-
1por Traoré, Bourama, Oliveira, Fabiano, Faye, Ousmane, Dicko, Adama, Coulibaly, Cheick A., Sissoko, Ibrahim M., Sibiry, Samake, Sogoba, Nafomon, Sangare, Moussa Brema, Coulibaly, Yaya I., Traore, Pierre, Traore, Sekou F., Anderson, Jennifer M., Keita, Somita, Valenzuela, Jesus G., Kamhawi, Shaden, Doumbia, Seydou“…Historically the western sahelian dry regions of Mali are known to be highly endemic for cutaneous leishmaniasis (CL) caused by Leishmania major, while cases are rarely reported from the Southern savanna forest of the country. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2por Pereira, Lais, Oliveira, Fabiano, Townsend, Shannon, Metangmo, Sonia, Meneses, Claudio, Moore, Ian N., Brodskyn, Claudia I., Valenzuela, Jesus G., Magez, Stefan, Kamhawi, Shaden“…Here, we determined the outcome of a chronic infection with Trypanosoma brucei brucei on cutaneous leishmaniasis (CL) caused by L. major. C57BL/6 mice infected with T. b. brucei were given a sub-curative treatment with diminazene aceturate then coinfected with L. major by vector bites. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3por Traoré, Bourama, Oliveira, Fabiano, Faye, Ousmane, Dicko, Adama, Coulibaly, Cheick A., Sissoko, Ibrahim M., Sibiry, Samake, Sogoba, Nafomon, Sangare, Moussa Brema, Coulibaly, Yaya I., Traore, Pierre, Traore, Sekou F., Anderson, Jennifer M., Keita, Somita, Valenzuela, Jesus G., Kamhawi, Shaden, Doumbia, SeydouEnlace del recurso
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
4por Rohoušová, Iva, Subrahmanyam, Sreenath, Volfová, Věra, Mu, Jianbing, Volf, Petr, Valenzuela, Jesus G., Jochim, Ryan C.“…Although P. tobbi transmits a cutaneous form of leishmaniasis, its salivary proteins are most similar to other Larroussius subgenus species transmitting visceral leishmaniasis. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
5“…Visceral leishmaniasis (VL) is a vector-borne disease transmitted by phlebotomine sand flies and remains the most serious form of the disease with no available human vaccine. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6por Duthie, Malcolm S., Pereira, Lais, Favila, Michelle, Hofmeyer, Kimberly A., Reed, S. Jim, Metangmo, Sonia, Townsend, Shannon, Laurance, John D., Picone, Alessandro, Misquith, Ayesha, Hossain, Faria, Ghosh, Prakash, Khan, Md Anik Ashfaq, Guderian, Jeffery, Bailor, H. Remy, Liang, Hong, Vergara, Julie, Oliveira, Fabiano, Howard, Randall F., Kamhawi, Shaden, Mondal, Dinesh, Coler, Rhea N., Valenzuela, Jesus G., Reed, Steven G.“…This is an important demonstration of vaccine protection against visceral leishmaniasis using a natural challenge model.…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
7por Cecílio, Pedro, Pérez-Cabezas, Begoña, Fernández, Laura, Moreno, Javier, Carrillo, Eugenia, Requena, José M., Fichera, Epifanio, Reed, Steven G., Coler, Rhea N., Kamhawi, Shaden, Oliveira, Fabiano, Valenzuela, Jesus G., Gradoni, Luigi, Glueck, Reinhard, Gupta, Gaurav, Cordeiro-da-Silva, Anabela“…Nevertheless, to date there is no vaccine available for human leishmaniasis. We optimized and assessed in vivo the safety and immunogenicity of an innovative vaccine candidate against human visceral leishmaniasis (VL), consisting of Virus-Like Particles (VLP) loaded with three different recombinant proteins (LJL143 from Lutzomyia longipalpis saliva as the vector-derived (VD) component, and KMP11 and LeishF3+, as parasite-derived (PD) antigens) and adjuvanted with GLA-SE, a TLR4 agonist. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8por Rohoušová, Iva, Subrahmanyam, Sreenath, Volfová, Věra, Mu, Jianbing, Volf, Petr, Valenzuela, Jesus G., Jochim, Ryan C.Enlace del recurso
Publicado 2012
Enlace del recurso
Online Artículo Texto -
9por Asojo, Oluwatoyin A., Kelleher, Alan, Liu, Zhuyun, Pollet, Jeroen, Hudspeth, Elissa M., Rezende, Wanderson C., Groen, Mallory Jo, Seid, Christopher A., Abdeladhim, Maha, Townsend, Shannon, de Castro, Waldione, Mendes-Sousa, Antonio, Bartholomeu, Daniella Castanheira, Fujiwara, Ricardo Toshio, Bottazzi, Maria Elena, Hotez, Peter J., Zhan, Bin, Oliveira, Fabiano, Kamhawi, Shaden, Valenzuela, Jesus G.“…Because of the importance of SALO as a potential component of a leishmaniasis vaccine, a plan to produce this recombinant protein for future scale manufacturing as well as knowledge of its structural characteristics are needed to move SALO forward for the clinical path. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
10Seroconversion to Lutzomyia intermedia LinB-13 as a biomarker for developing cutaneous leishmaniasispor Carvalho, Augusto M., Fukutani, Kiyoshi F., Sharma, Rohit, Curvelo, Rebecca P., Miranda, José Carlos, Barral, Aldina, Carvalho, Edgar M., Valenzuela, Jesus G., Oliveira, Fabiano, de Oliveira, Camila I.Enlace del recurso
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11por Marzouki, Soumaya, Zaraa, Ines, Abdeladhim, Maha, Benabdesselem, Chaouki, Oliveira, Fabiano, Kamhawi, Shaden, Mokni, Mourad, Louzir, Hechmi, Valenzuela, Jesus G., Ahmed, Melika Ben“…A possible etiological link between the onset of endemic pemphigus in Tunisia and bites of Phlebotomus papatasi, the vector of zoonotic cutaneous leishmaniasis, has been previously suggested. We hypothesized that the immunodominant P. papatasi salivary protein PpSP32 binds to desmogleins 1 and 3 (Dsg1 and Dsg3), triggering loss of tolerance to these pemphigus target autoantigens. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
12por Aoki, Valeria, Abdeladhim, Maha, Li, Ning, Cecilio, Pedro, Prisayanh, Phillip, Diaz, Luis A., Valenzuela, Jesus G.“…Prominent among these diseases is Leishmaniasis that affects the skin and mucous surfaces and organs such as liver and spleen. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13por Karmakar, Subir, Volpedo, Greta, Zhang, Wen-Wei, Lypaczewski, Patrick, Ismail, Nevien, Oliveira, Fabiano, Oristian, James, Meneses, Claudio, Gannavaram, Sreenivas, Kamhawi, Shaden, Hamano, Shinjiro, Valenzuela, Jesus G., Matlashewski, Greg, Satoskar, Abhay R., Dey, Ranadhir, Nakhasi, Hira L.“…Leishmaniasis is one of the top neglected tropical diseases with significant morbidity and mortality in low and middle-income countries (LMIC). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14por Mondragon-Shem, Karina, Al-Salem, Waleed S., Kelly-Hope, Louise, Abdeladhim, Maha, Al-Zahrani, Mohammed H., Valenzuela, Jesus G., Acosta-Serrano, Alvaro“…BACKGROUND: The sandfly Phlebotomus papatasi is the vector of Leishmania major, the main causative agent of Old World cutaneous leishmaniasis (CL) in Saudi Arabia. Sandflies inject saliva while feeding and the salivary protein PpSP32 was previously shown to be a biomarker for bite exposure. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15por Solcà, Manuela S., Andrade, Bruno B., Abbehusen, Melissa Moura Costa, Teixeira, Clarissa R., Khouri, Ricardo, Valenzuela, Jesus G., Kamhawi, Shaden, Bozza, Patrícia Torres, Fraga, Deborah Bittencourt Mothé, Borges, Valeria Matos, Veras, Patrícia Sampaio Tavares, Brodskyn, Claudia Ida“…Clinical manifestations in canine visceral leishmaniasis (CVL) have not been clearly associated with immunological status or disease progression. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
16por Mondragon-Shem, Karina, Al-Salem, Waleed S., Kelly-Hope, Louise, Abdeladhim, Maha, Al-Zahrani, Mohammed H., Valenzuela, Jesus G., Acosta-Serrano, AlvaroEnlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
17por Karmakar, Subir, Ismail, Nevien, Oliveira, Fabiano, Oristian, James, Zhang, Wen Wei, Kaviraj, Swarnendu, Singh, Kamaleshwar P., Mondal, Abhishek, Das, Sushmita, Pandey, Krishna, Bhattacharya, Parna, Volpedo, Greta, Gannavaram, Sreenivas, Satoskar, Monika, Satoskar, Sanika, Sastry, Rajiv M., Oljuskin, Timur, Sepahpour, Telly, Meneses, Claudio, Hamano, Shinjiro, Das, Pradeep, Matlashewski, Greg, Singh, Sanjay, Kamhawi, Shaden, Dey, Ranadhir, Valenzuela, Jesus G., Satoskar, Abhay, Nakhasi, Hira L.“…Visceral Leishmaniasis (VL), a potentially fatal disease is caused by Leishmania donovani parasites with no vaccine available. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
18por Souza, Ana Paula, Andrade, Bruno Bezerril, Aquino, Dorlene, Entringer, Petter, Miranda, José Carlos, Alcantara, Ruan, Ruiz, Daniel, Soto, Manuel, Teixeira, Clarissa R., Valenzuela, Jesus G., de Oliveira, Camila Indiani, Brodskyn, Cláudia Ida, Barral-Netto, Manoel, Barral, Aldina“…METHODOLOGY/PRINCIPAL FINDINGS: ELISA was used to screen human sera, collected in an area endemic for visceral leishmaniasis, against the salivary gland sonicate (SGS) or two recombinant proteins (rLJM11 and rLJM17) from Lutzomyia longipalpis saliva. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
19por Roatt, Bruno Mendes, Aguiar-Soares, Rodrigo Dian de Oliveira, Reis, Levi Eduardo Soares, Cardoso, Jamille Mirelle de Oliveira, Mathias, Fernando Augusto Siqueira, de Brito, Rory Cristiane Fortes, da Silva, Sydnei Magno, Gontijo, Nelder De Figueiredo, Ferreira, Sidney de Almeida, Valenzuela, Jesus G., Corrêa-Oliveira, Rodrigo, Giunchetti, Rodolfo Cordeiro, Reis, Alexandre Barbosa“…Herein, we evaluated the treatment strategy employing a therapeutic heterologous vaccine composed of antigens of Leishmania braziliensis associated with MPL adjuvant (LBMPL vaccine) for visceral leishmaniasis (VL) in symptomatic dogs naturally infected by Leishmania infantum. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
20por Collin, Nicolas, Gomes, Regis, Teixeira, Clarissa, Cheng, Lily, Laughinghouse, Andre, Ward, Jerrold M., Elnaiem, Dia-Eldin, Fischer, Laurent, Valenzuela, Jesus G., Kamhawi, Shaden“…Immunity to a sand fly salivary protein protects against visceral leishmaniasis (VL) in hamsters. This protection was associated with the development of cellular immunity in the form of a delayed-type hypersensitivity response and the presence of IFN-γ at the site of sand fly bites. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto